- Orix’s net income forecast for the fiscal year comes in below estimates, with a projection of 390.00 billion yen versus the expected 394.13 billion yen.
- The estimated dividend also falls short of predictions at 98.60 yen, compared to the estimate of 121.74 yen.
- Quarterly results reveal a substantial increase in net income, amounting to 126.93 billion yen compared to 61.69 billion yen year on year, even exceeding estimates of 112.66 billion yen.
- Net sales also show impressive growth, pushing to 776.50 billion yen, which represents a 16% increase year on year, and surpasses estimates of 745.6 billion yen.
- The company’s stock is generally seen as a good investment, with six buys, four holds, and zero sells.
- All these comparisons have been made based on figures reported directly from the company’s original disclosures.
A look at Orix Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
With a strong momentum score of 5, Orix Corp is poised for impressive performance in the long term. This indicates a positive trend in the company’s stock price, suggesting potential growth opportunities ahead. Additionally, Orix Corp also receives high scores of 4 in both value and dividend categories, reflecting its solid financial position and commitment to rewarding investors.
While Orix Corp scores slightly lower in growth and resilience factors, with scores of 3 and 2 respectively, the company’s diversified business lines, including leasing, real estate loans, and banking, provide a stable foundation for future growth. Despite challenges, Orix Corp‘s resilience score of 2 indicates a moderate ability to weather economic downturns, further supported by its comprehensive financial services offered worldwide.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
